174 related articles for article (PubMed ID: 30338511)
1. Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls.
Forslund M; Landin-Wilhelmsen K; Schmidt J; Brännström M; Trimpou P; Dahlgren E
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):320-326. PubMed ID: 30338511
[TBL] [Abstract][Full Text] [Related]
2. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities.
Figurová J; Dravecká I; Javorský M; Petríková J; Lazúrová I
Wien Klin Wochenschr; 2016 Sep; 128(17-18):641-8. PubMed ID: 25787215
[TBL] [Abstract][Full Text] [Related]
4. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
6. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?
Talbott EO; Zborowski J; Rager J; Stragand JR
Vasc Health Risk Manag; 2008; 4(2):453-62. PubMed ID: 18561521
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
8. Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.
Winters SJ; Talbott E; Guzick DS; Zborowski J; McHugh KP
Fertil Steril; 2000 Apr; 73(4):724-9. PubMed ID: 10731532
[TBL] [Abstract][Full Text] [Related]
9. Fecundity among women with polycystic ovary syndrome (PCOS)-a population-based study.
Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Sundström-Poromaa I
Hum Reprod; 2019 Oct; 34(10):2052-2060. PubMed ID: 31504532
[TBL] [Abstract][Full Text] [Related]
10. Prediction of age at menopause in women with polycystic ovary syndrome.
Minooee S; Ramezani Tehrani F; Rahmati M; Mansournia MA; Azizi F
Climacteric; 2018 Feb; 21(1):29-34. PubMed ID: 29106305
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D predictors in polycystic ovary syndrome: a meta-analysis.
Bacopoulou F; Kolias E; Efthymiou V; Antonopoulos CN; Charmandari E
Eur J Clin Invest; 2017 Oct; 47(10):746-755. PubMed ID: 28795765
[TBL] [Abstract][Full Text] [Related]
12. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
Hudecova M; Holte J; Olovsson M; Larsson A; Berne C; Sundstrom-Poromaa I
Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228
[TBL] [Abstract][Full Text] [Related]
14. Common diseases as determinants of menopausal age.
Li J; Eriksson M; Czene K; Hall P; Rodriguez-Wallberg KA
Hum Reprod; 2016 Dec; 31(12):2856-2864. PubMed ID: 27798047
[TBL] [Abstract][Full Text] [Related]
15. Association between polycystic ovary syndrome and hot flash presentation during the midlife period.
Yin O; Zacur HA; Flaws JA; Christianson MS
Menopause; 2018 Jun; 25(6):691-696. PubMed ID: 29360703
[TBL] [Abstract][Full Text] [Related]
16. Associations between psychologic symptoms and life satisfaction in women with polycystic ovary syndrome.
Cipkala-Gaffin J; Talbott EO; Song MK; Bromberger J; Wilson J
J Womens Health (Larchmt); 2012 Feb; 21(2):179-87. PubMed ID: 22004245
[TBL] [Abstract][Full Text] [Related]
17. Predictors of hypertensive disorders in pregnancy in women with and without polycystic ovary syndrome: The Australian Longitudinal Study of Women's Health.
Bahri Khomami M; Earnest A; Loxton D; Teede HJ; Joham AE
Clin Endocrinol (Oxf); 2021 Aug; 95(2):323-331. PubMed ID: 33639011
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
19. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
